These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer. Rappaport JA; Waldman SA Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1125-1137. PubMed ID: 32945718 [No Abstract] [Full Text] [Related]
10. TCR Retrogenic Mice as a Model To Map Self-Tolerance Mechanisms to the Cancer Mucosa Antigen GUCY2C. Abraham TS; Flickinger JC; Waldman SA; Snook AE J Immunol; 2019 Feb; 202(4):1301-1310. PubMed ID: 30642983 [TBL] [Abstract][Full Text] [Related]
11. T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C. Flickinger JC; Singh J; Yarman Y; Carlson RD; Barton JR; Waldman SA; Snook AE Front Immunol; 2022; 13():855759. PubMed ID: 35355987 [TBL] [Abstract][Full Text] [Related]
13. Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease. Snook AE; Li P; Stafford BJ; Faul EJ; Huang L; Birbe RC; Bombonati A; Schulz S; Schnell MJ; Eisenlohr LC; Waldman SA Cancer Res; 2009 Apr; 69(8):3537-44. PubMed ID: 19351847 [TBL] [Abstract][Full Text] [Related]
14. GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer. Lisby AN; Flickinger JC; Bashir B; Weindorfer M; Shelukar S; Crutcher M; Snook AE; Waldman SA Expert Rev Precis Med Drug Dev; 2021; 6(2):117-129. PubMed ID: 34027103 [TBL] [Abstract][Full Text] [Related]
15. A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity. Song DG; Ye Q; Poussin M; Liu L; Figini M; Powell DJ Oncotarget; 2015 Aug; 6(25):21533-46. PubMed ID: 26101914 [TBL] [Abstract][Full Text] [Related]
16. The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Rappaport JA; Waldman SA Front Oncol; 2018; 8():299. PubMed ID: 30131940 [TBL] [Abstract][Full Text] [Related]